Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial
Matthew D Campbell, Mark Walker, Michael I Trenell, Steven Luzio, Gareth Dunseath, Daniel Tuner, Richard M Bracken, Stephen C Bain, Mark Russell, Emma J Stevenson, Daniel J West, Matthew D Campbell, Mark Walker, Michael I Trenell, Steven Luzio, Gareth Dunseath, Daniel Tuner, Richard M Bracken, Stephen C Bain, Mark Russell, Emma J Stevenson, Daniel J West
Abstract
Aim: To examine the metabolic, gluco-regulatory-hormonal and inflammatory cytokine responses to large reductions in rapid-acting insulin dose administered prandially before and after intensive running exercise in male type 1 diabetes patients.
Methods: This was a single centre, randomised, controlled open label study. Following preliminary testing, 8 male patients (24±2 years, HbA1c 7.7±0.4%/61±4 mmol.l-1) treated with insulin's glargine and aspart, or lispro attended the laboratory on two mornings at ∼08:00 h and consumed a standardised breakfast carbohydrate bolus (1 g carbohydrate.kg-1BM; 380±10 kcal) and self-administered a 75% reduced rapid-acting insulin dose 60 minutes before 45 minutes of intensive treadmill running at 73.1±0.9% VO2peak. At 60 minutes post-exercise, patients ingested a meal (1 g carbohydrate.kg-1BM; 660±21 kcal) and administered either a Full or 50% reduced rapid-acting insulin dose. Blood glucose and lactate, serum insulin, cortisol, non-esterified-fatty-acids, β-Hydroxybutyrate, and plasma glucagon, adrenaline, noradrenaline, IL-6, and TNF-α concentrations were measured for 180 minutes post-meal.
Results: All participants were analysed. All glycaemic, metabolic, hormonal, and cytokine responses were similar between conditions up to 60 minutes following exercise. Following the post-exercise meal, serum insulin concentrations were lower under 50% (p<0.05) resulting in 75% of patients experiencing hyperglycaemia (blood glucose ≥8.0 mmol.l-1; 50% n = 6, Full n = 3). β-Hydroxybutyrate concentrations decreased similarly, such that at 180 minutes post-meal concentrations were lower than rest under Full and 50%. IL-6 and TNF-α concentrations remained similar to fasting levels under 50% but declined under Full. Under 50% IL-6 concentrations were inversely related with serum insulin concentrations (r = -0.484, p = 0.017).
Conclusions: Heavily reducing rapid-acting insulin dose with a carbohydrate bolus before, and a meal after intensive running exercise may cause hyperglycaemia, but does not augment ketonaemia, raise inflammatory cytokines TNF-α and IL-6 above fasting levels, or cause other adverse metabolic or hormonal disturbances.
Trial registration: ClinicalTrials.gov NCT01531855.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Chu L, Hamilton J, Riddell MC (2011) Clinical management of the physically active patient with type 1 diabetes. Physiol Sports Med 39: 64–77.
- West DJ, Morton RD, Bain SC, Stephens JW, Bracken RM (2010) Blood glucose responses to reductions in pre-exercise rapid-acting insulin for 24 h after running in individuals with type 1 diabetes. J Sports Sci 28: 781–788.
- Rabasa-Lhoret R, Bourque J, Ducros F, Chiasson JL (2001) Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Diabetes Care 24: 625–630.
- Campbell MD, Walker M, Trenell MI, Jakovljevic DG, Stevenson EJ, et al. (2013) Large Pre-and Postexercise Rapid-Acting Insulin Reductions Preserves Glycemia and Prevents Early-but Not Late-Onset Hypoglycemia in Patients With Type 1 Diabetes. Diabetes Care 36: 2217–2224.
- Khani S, Tayek JA (2001) Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clin Sci 101: 739–747.
- Laffel L (2000) Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Rev 15: 412–426.
- Rosa JS, Flores RL, Oliver SR, Pontello AM, Zaldivar FP, et al. (2008) Sustained IL-1α, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatric Diabetes 9: 9–16.
- Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, et al. (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans role of oxidative stress. Circulation 106: 2067–2072.
- Targher G, Zenari L, Bertolini L, Muggeo M, Zoppini G (2001) Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications. Diabetes Care 24: 956–957.
- De Rekeneire N, Peila R, Ding J, Colbert LH, Visser M, et al. (2006) Diabetes, Hyperglycemia, and Inflammation in Older Individuals The Health, Aging and Body Composition study. Diabetes Care 29: 1902–1908.
- Febbraio MA, Pedersen BK (2005) Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exerc Sport Sci Rev 33: 114–119.
- Stouthard J, Romijn JA, Van der Poll T, Endert E, Klein S, et al. (1995) Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol-Endoc Metab 268: E813–E819.
- Karavanaki K, Kakleas K, Georga S, Bartzeliotou Α, Mavropoulos G, et al. (2012) Plasma high sensitivity C-reactive protein and its relationship with cytokine levels in children with newly diagnosed type 1 diabetes and ketoacidosis. Clin Biochem 45: 1383–1388.
- Karavanaki K, Karanika E, Georga S, Bartzeliotou A, Tsouvalas M, et al. (2011) Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocr J58: 1045.
- Petersen AMW, Pedersen BK (2005) The anti-inflammatory effect of exercise. J App Phys 98: 1154–1162.
- Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK (1999) Pro-and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 515: 287–291.
- Sprenger H, Jacobs C, Nain M, Gressner A, Prinz H, et al. (1992) Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin immunol and immunop 63: 188–195.
- Drenth J, Van Uum S, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, et al. (1995) Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production. J App Physiol 79: 1497–1503.
- Nehlsen-Cannarella S, Fagoaga O, Nieman D, Henson D, Butterworth D, et al. (1997) Carbohydrate and the cytokine response to 2.5 h of running. J App Physiol 82: 1662–1667.
- Pedersen BK, Hoffman-Goetz L (2000) Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80: 1055–1081.
- Nemet D, Oh Y, Kim H-S, Hill M, Cooper DM (2002) Effect of intense exercise on inflammatory cytokines and growth mediators in adolescent boys. Pediatrics 110: 681–689.
- Tonoli C, Heyman E, Roelands B, Buyse L, Cheung SS, et al. (2012) Effects of Different Types of Acute and Chronic (Training) Exercise on Glycaemic Control in Type 1 Diabetes Mellitus: A Meta-Analysis. Sports Med 42: 1059–1080.
- Bracken R, West D, Stephens J, Kilduff L, Luzio S, et al. (2011) Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in Type 1 diabetes. Diabet Med 28: 218–222.
- Diamond M, Simonson D, DeFronzo R (1989) Menstrual cyclicity has a profound effect on glucose homeostasis. Fertility and sterility 52: 204–208.
- ACSM (2010) Clinical Exercise Testing. In: Walter R, Gordon NF, Pescatello LS, ACSM's guidelines for exercise testing and prescription. 8th ed. Baltimore: American College of Sports Medicine.
- Dill D, Costill DL (1974) Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J App Physiol 37: 247–248.
- West DJ, Stephens JW, Bain SC, Kilduff LP, Luzio S, et al. (2011) A combined insulin reduction and carbohydrate feeding strategy 30 min before running best preserves blood glucose concentration after exercise through improved fuel oxidation in type 1 diabetes mellitus. J Sports Sci 29: 279–289.
- Hopkins W (2006) Estimating sample size for magnitude-based inferences. J Sport Sci 10: 63–70.
- Marliss EB, Vranic M (2002) Intense Exercise Has Unique Effects on Both Insulin Release and Its Roles in Glucoregulation Implications for Diabetes. Diabetes 51: 271–283.
- McGarry J (1996) Ellenberg and Rifkin's Diabetes Mellitus. In: Porte D, Sherwin RS, Baron A, JAMA: J Am Med Assoc. 5 ed. New York: McGraw-Hill. pp. 19–28.
- Balasse EO, Féry F (1989) Ketone body production and disposal: effects of fasting, diabetes, and exercise. Diabetes Metab Rev 5: 247–270.
- Kalra PR, Tigas S (2002) Regulation of lipolysis: natriuretic peptides and the development of cachexia. Int J Cardiol 85: 125–132.
- Fowler MJ (2008) Microvascular and macrovascular complications of diabetes. Clinical Diabetes 26: 77–82.
- Daneman D (2006) Type 1 diabetes. The Lancet 367: 847–858.
- Galassetti P, Iwanaga K, Pontello A, Zaldivar F, Flores R, et al. (2006) Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes. Am J Physiol-Endocrinol Metab 290: E833–E839.
- Galassetti PR, Iwanaga K, Crisostomo M, Zaldivar FP, Larson J, et al. (2006) Inflammatory cytokine, growth factor and counterregulatory responses to exercise in children with type 1 diabetes and healthy controls. Pediatric Diabetes 7: 16–24.
- Rosa JS, Oliver SR, Flores RL, Ngo J, Milne GL, et al. (2011) Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes. Pediatric Diabetes 12: 464–472.
- Rosa JS, Flores RL, Oliver SR, Pontello AM, Zaldivar FP, et al. (2010) Resting and exercise-induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the previous 3 days. J App Physiol 108: 334–342.
- Jentjens R, Jeukendrup AE (2003) Determinants of post-exercise glycogen synthesis during short-term recovery. Sports Med 33: 117–144.
- Pedersen BK, Febbraio MA (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physioll Rev 88: 1379–1406.
- Viardot A, Grey ST, Mackay F, Chisholm D (2007) Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 148: 346–353.
- Cryer PE (2008) The barrier of hypoglycemia in diabetes. Diabetes 57: 3169–3176.
- Brown RJ, Sinaii N, Rother KI (2008) Too Much Glucagon, Too Little Insulin Time course of pancreatic islet dysfunction in new-onset type 1 diabetes. Diabetes Care 31: 1403–1404.
Source: PubMed